SAN
103.98
+0.48%↑
SHL.DE
55.4
+0.54%↑
PHIA
24.26
+0.96%↑
SRT3
241.7
-2.89%↓
ORNBV.FI
52.44
-0.19%↓
SAN
103.98
+0.48%↑
SHL.DE
55.4
+0.54%↑
PHIA
24.26
+0.96%↑
SRT3
241.7
-2.89%↓
ORNBV.FI
52.44
-0.19%↓
SAN
103.98
+0.48%↑
SHL.DE
55.4
+0.54%↑
PHIA
24.26
+0.96%↑
SRT3
241.7
-2.89%↓
ORNBV.FI
52.44
-0.19%↓
SAN
103.98
+0.48%↑
SHL.DE
55.4
+0.54%↑
PHIA
24.26
+0.96%↑
SRT3
241.7
-2.89%↓
ORNBV.FI
52.44
-0.19%↓
SAN
103.98
+0.48%↑
SHL.DE
55.4
+0.54%↑
PHIA
24.26
+0.96%↑
SRT3
241.7
-2.89%↓
ORNBV.FI
52.44
-0.19%↓
24h
Actual
Mínimo
135.1
Máximo
135.65
Ingresos | 202M 809M |
---|---|
Ventas | -194M 5.3B |
P/B Media del Sector | 26.27 73.394 |
BPA | 2.2 |
Rentabilidad por dividendo | 1.34 |
Margen de beneficio | 15.363 |
EBITDA | 85M 1.6B |
Recomendaciones | Compra Fuerte |
---|---|
Estimación a 12 meses | +30.26 upside |
Rentabilidad por dividendo Media del Sector | 1.34% 3.09% |
---|---|
Próximas Ganancias | 6 mar 2025 |
Capitalización de Mercado | 33B 98B |
---|---|
Apertura anterior | 136.2 |
Cierre anterior | 135.5 |
By Trading Central
Confianza
Strong Bearish Evidence
134.7 / 135.55 Soporte y Resistencia
El rendimiento pasado no es un indicador fiable de resultados futuros.
11 feb 2025, 07:03 UTC
Germany's Merck in Talks to Buy SpringWorks Therapeutics
DJ
Leer
10 feb 2025, 16:38 UTC
SpringWorks Therapeutics Shares Rise on Report it May be Acquired
DJ
Leer
14 nov 2024, 08:09 UTC
Merck KGaA Earnings Growth Beats Expectations -- Update
DJ
Leer
14 nov 2024, 06:26 UTC
Merck KGaA Expects Sales at Lower End of Outlook Range After Third-Quarter Miss
DJ
Leer
11 feb 2025, 16:45 UTC
Merck's Potential Springworks Deal Unlikely to Move Needle on Earnings -- Market Talk
DJ
Leer
11 feb 2025, 10:54 UTC
Germany's Merck Potential Buy of SpringWorks Therapeutics Puts Its Strategy Into Question -- Market Talk
DJ
Leer
11 feb 2025, 10:52 UTC
German Merck's Potential Buy of SpringWorks Therapeutics Holds Profitability Risk -- Market Talk
DJ
Leer
6 ene 2025, 13:08 UTC
Merck KGaA: Transaction closed on Dec. 23, 2024
DJ
Leer
6 ene 2025, 13:07 UTC
Merck KGaA: Didn't Disclose Financial Details
DJ
Leer
6 ene 2025, 13:06 UTC
Merck KGaA: HUB's Organoid Offering Complements Merck KGaA's Cell Culture Portfolio
DJ
Leer
6 ene 2025, 13:04 UTC
Merck KaA Acquires HUB Organoids Holding B.V. to Expand Its Next-Generation Biology Portfolio
DJ
Leer
17 dic 2024, 13:05 UTC
Merck: Deal Expected to Close By End Dec. 2024
DJ
Leer
17 dic 2024, 13:04 UTC
Merck: Terms of Deal Undisclosed
DJ
Leer
17 dic 2024, 13:04 UTC
Merck Signs Pact to Buy HUB Organoids
DJ
Leer
17 dic 2024, 13:03 UTC
Merck: Acquisition Advances Next Gen Biology Portfolio
DJ
Leer
17 dic 2024, 13:03 UTC
Merck to Buy HUB Organoids Holding
DJ
Leer
14 nov 2024, 11:15 UTC
Merck KGaA's Sales Target Dragged by Muted China Outlook -- Market Talk
DJ
Leer
14 nov 2024, 10:45 UTC
Merck KGaA's Life-Science Sales Recovery Is Encouraging -- Market Talk
DJ
Leer
14 nov 2024, 09:26 UTC
Merck KGaA's Electronics Division Disappointed -- Market Talk
DJ
Leer
14 nov 2024, 06:00 UTC
Merck KGaA Sees 2024 EBITDA Before One-Time Items Around Mid-Point Of Range
DJ
Leer
14 nov 2024, 06:00 UTC
Merck KGaA Had Seen 2024 Net Sales Between EUR20.7B and EUR22.1B
DJ
Leer
14 nov 2024, 06:00 UTC
Merck KGaA 3Q EBITDA EUR1.55B .
DJ
Leer
14 nov 2024, 06:00 UTC
Merck KGaA Sees 2024 EPS Pre Around Mid-Point of EUR8.20 to EUR9.30
DJ
Leer
14 nov 2024, 06:00 UTC
Analysts Saw Merck KGaA 3Q Ebitda Before One-Time Items at EUR1.55B
DJ
Leer
14 nov 2024, 06:00 UTC
Merck KGaA Backs 2024 View
DJ
Leer
14 nov 2024, 06:00 UTC
Merck KGaA 3Q Sales EUR5.27B
DJ
Leer
14 nov 2024, 06:00 UTC
Analysts Saw Merck KGaA 3Q Net Sales at EUR5.33B
DJ
Leer
14 nov 2024, 06:00 UTC
Merck KGaA: 3Q Life Science Returns to Organic Sales Growth
DJ
Leer
14 nov 2024, 06:00 UTC
Merck KGaA Had Seen 2024 EBITDA Before One-Time Items Between EUR5.8B to EUR6.4B
DJ
Leer
14 nov 2024, 06:00 UTC
Merck KGaA Expects 2024 Net Sales In Lower Half Of Range
DJ
Leer
Cambio de precio
By TipRanks
Estimación a 12 meses
Media 176.5 EUR 30.26%
Máximo 190 EUR
Mínimo 160 EUR
De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Merck KGaA Dist en los últimos 3 meses.
By TipRanks
Compra Fuerte
8 ratings
6
Comprar
2
Mantener
0
Vender
De acuerdo con 8 analistas que ofrecen calificaciones bursátiles a para Merck KGaA Dist en los últimos 3 meses.
By Trading Central
Corto Plazo
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Medio plazo
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Largo Plazo
Strong Bearish Evidence
All events are bearish.
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$